Swipe om te navigeren naar een ander artikel
The aim of the study is to examine the health-related quality-of-life (HRQOL) impact of the nocturnal awakenings and the duration of the sleep in the Finnish middle-aged and older population.
Cross-sectional sample consisted of 823 community-dwelling persons aged 55–75 living in a single municipality in a rural area of Eastern Finland. Frequency of the nocturnal awakenings was dichotomized as reporting “frequent,” if the participant reported subjectively awakening “often” or “very often,” and “infrequent” if the participant reported awakening “sometimes” or less frequently. HRQOL was measured with a preference-based HRQOL-index instrument, 15D. Analyses were adjusted for gender, BMI, morbidities, depression, employment and marital status, current smoking and drinking, exercise, recommendation to exercise from a health care professional, and subjective opinion about own exercise habits.
Frequent nocturnal awakenings had statistically and clinically significant negative impact on HRQOL, the mean (SE) adjusted marginal HRQOL impact being −0.0416 (0.006). More than 10 and less than 6.5 h of daily sleep were associated with higher probability of having low HRQOL, adjusted odd ratios (95 % CI) being 2.65 (1.11–6.33) and 2.65 (1.55–4.52), respectively. However, the changes in daily sleep duration did not have noticeable influence on the significance or magnitude of the negative HRQOL impact of the frequent nocturnal awakenings.
Nocturnal awakenings displayed a strong independent association with decreased HRQOL. The findings suggest that both clinicians and researchers should pay closer attention to nocturnal awakenings and other sleep problems in order to find ways to improve the quality of life in individuals with such conditions.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Ohayon, M. M. (2009). Nocturnal awakenings and comorbid disorders in the American general population. Journal of Psychiatric Research, 43, 48–54. CrossRef
Hublin, C., Partinen, M., Koskenvuo, M., et al. (2007). Sleep and mortality: A population-based 22-year follow-up study. Sleep, 30, 1245–1253. PubMed
Lee, M., Choh, A. C., Demerath, E. W., et al. (2009). Sleep disturbances in relation to health-related quality of life in adults: The Fels longitudinal study. Journal of Nutrition Health and Aging, 13, 576–583. CrossRef
Luyster, F. S., & Dunbar-Jacob, J. (2011). Sleep quality and quality of life in adults with Type 2 diabetes. Diabetes Education, 37, 347–355. CrossRef
Simon, D. K., Morgen, K., & Espie, C. A. (2010). Insomnia and health-related quality of life. Sleep Medicine Reviews, 14, 69–82. CrossRef
Soini, E. J., & Hallinen, T. A. (2009). Cost-utility of agomelatine, venlafaxine and placebo in the treatment of major depressive disorder (MDD) in Finland—Economic modelling study using representative population data. Value in Health, 12, A359. CrossRef
Roth, T., Coulouvrat, C., Hajak, G., et al. (2011). Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International statistical classification of diseases and related health problems, tenth revision; and research diagnostic criteria/international classification of sleep disorders, Second Edition Criteria: Results from the America Insomnia Survey. Biological Psychiatry, 69, 592–600. PubMedCrossRef
Saramies, J. (2005). Risk factors of type 2 diabetes and screening of abnormal glucose metabolism in primary health care: Dissertation. Oulu: Faculty of Medicine, Department of Public Health Science and General Practice, University of Oulu.
Sintonen, H. (1994) The 15D-measure of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. Melbourne: National Centre for Health Program Evaluation, Working Paper 41.
Sintonen, H. (1995) The 15D-measure of health-related quality of life. II. Feasibility, reliability and validity of its valuation system. Melbourne: National Centre for Health Program Evaluation, Working Paper 42.
Sintonen, H. (1994). Outcome measurement in acid-related diseases. Pharmacoeconomics, 5(Suppl 3), 17–26. CrossRef
Beck, A. T., Ward, C. H., Mendelson, M., et al. (1961). An inventory for measuring depression. Archives General Psychiatry, 4, 561–571. CrossRef
Raitasalo, R. (1977). Depressio ja sen yhteys psykoterapian tarpeeseen. Helsinki: Kansaneläkelaitoksen julkaisuja A: 13.
Raitasalo, R. (2007). Mood questionnaire. Finnish modification of the short form of the Beck Depression Inventory measuring depression symptoms and self-esteem. Helsinki: The Social Insurance Institution, Finland. Studies in social security and health 86.
Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the beck depression inventory: Twenty-five years of evaluation. Clinical Psychology Reviews, 8, 77–100. CrossRef
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates.
Hedges, L., & Olkin, I. (1985). Statistical methods for meta-analysis. New York: Academic Press.
Gill, J. (2000). Generalized linear models: A unified approach. Thousand Oaks, CA: Sage University Papers Series on Quantitative Applications in the Social Sciences.
Kupelian, V., Wei, J., O’Leary, M., Norgaard, J., Rosen, R., & McKinlay, J. (2012). Nocturia and quality of life: Results from the Boston area community health survey. European Journal of Urology, 61, 78–84. CrossRef
- The health-related quality-of-life impact of nocturnal awakenings in the middle-aged and older Finnish population
- Springer Netherlands